Efficacy and safety of endoscopic submucosal dissection for colorectal dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: In this meta-analysis, we studied the safety and efficacy of endoscopic submucosal dissection (ESD) for colorectal dysplasia in patients with inflammatory bowel disease (IBD). Methods: Multiple databases were searched, and studies were retrieved based on pre-specified criteria until October 2022. The outcomes assessed were resection rates, procedural complications, local recurrence, metachronous tumors, and the need for surgery after ESD in IBD. Standard meta-analysis methods were followed using the random-effects model, and I2% was used to assess heterogeneity. Results: Twelve studies comprising 291 dysplastic lesions in 274 patients were included with a median follow-up of 25 months. The pooled en-bloc resection, R0 resection, and curative resection rates were 92.5% (95% confidence interval [CI], 87.9%–95.4%; I2=0%), 81.5% (95% CI, 72.5%–88%; I2=43%), and 48.9% (95% CI, 32.1%–65.9%; I2=87%), respectively. The local recurrence rate was 3.9% (95% CI, 2%–7.5%; I2=0%). The pooled rates of bleeding and perforation were 7.7% (95% CI, 4.5%–13%; I2=10%) and 5.3% (95% CI, 3.1%–8.9%; I2=0%), respectively. The rates of metachronous recurrence and additional surgery following ESD were 10% (95% CI, 5.2%–18.2%; I2=55%) and 13% (95% CI, 8.5%–19.3%; I2=54%), respectively. Conclusions: ESD is safe and effective for the resection of dysplastic lesions in IBD with an excellent pooled rate of en-bloc and R0 resection.
Abstract
Background/Aims: In this meta-analysis, we studied the safety and efficacy of endoscopic submucosal dissection (ESD) for colorectal dysplasia in patients with inflammatory bowel disease (IBD). Methods: Multiple databases were searched, and studies were retrieved based on pre-specified criteria until October 2022. The outcomes assessed were resection rates, procedural complications, local recurrence, metachronous tumors, and the need for surgery after ESD in IBD. Standard meta-analysis methods were followed using the random-effects model, and I2% was used to assess heterogeneity. Results: Twelve studies comprising 291 dysplastic lesions in 274 patients were included with a median follow-up of 25 months. The pooled en-bloc resection, R0 resection, and curative resection rates were 92.5% (95% confidence interval [CI], 87.9%–95.4%; I2=0%), 81.5% (95% CI, 72.5%–88%; I2=43%), and 48.9% (95% CI, 32.1%–65.9%; I2=87%), respectively. The local recurrence rate was 3.9% (95% CI, 2%–7.5%; I2=0%). The pooled rates of bleeding and perforation were 7.7% (95% CI, 4.5%–13%; I2=10%) and 5.3% (95% CI, 3.1%–8.9%; I2=0%), respectively. The rates of metachronous recurrence and additional surgery following ESD were 10% (95% CI, 5.2%–18.2%; I2=55%) and 13% (95% CI, 8.5%–19.3%; I2=54%), respectively. Conclusions: ESD is safe and effective for the resection of dysplastic lesions in IBD with an excellent pooled rate of en-bloc and R0 resection.
참고문헌 (34)
- Jess T, "Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years", Gastroenterology, 143, pp.375~381 (2012)
- Eaden JA, "The risk of colorectal cancer in ulcerative colitis : a meta-analysis", Gut, 48, pp.526~535 (2001)
- Choi CH, "Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis : an updated overview", Am J Gastroenterol, 110, pp.1022~1034 (2015)
- Pimentel-Nunes P, "Endoscopic submucosal dissection : European Society of Gastrointestinal Endoscopy(ESGE)Guideline", Endoscopy, 47, pp.829~854 (2015)
- Laine L, "SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease", Gastroenterology, 148, pp.639~651 (2015)
- American Society for Gastrointestinal Endoscopy Standards of Practice Committee, "The role of endoscopy in inflammatory bowel disease", Gastrointest Endosc, 81, pp.1101~1121 (2015)
- Rutter MD, "Colorectal dysplasia in inflammatory bowel disease : a clinicopathologic perspective", Clin Gastroenterol Hepatol, 12, pp.359~367 (2014)
- Draganov PV, "AGA institute clinical practice update : endoscopic submucosal dissection in the United States", Clin Gastroenterol Hepatol, 17, pp.16~25 (2019)
- Uraoka T, "Colorectal endoscopic submucosal dissection in Japan and Western countries", Dig Endosc, 24(Suppl 1), pp.80~83 (2012)
- Hurlstone DP, "Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis : can we change the endoscopic management paradigm?", Gut, 56, pp.838~846 (2007)
- Wang J, "Endoscopic submucosal dissection vs endoscopic mucosal resection for colorectal tumors : a meta-analysis", World J Gastroenterol, 20, pp.8282~8287 (2014)
- Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", Syst Rev, 10, pp.89~ (2021)
- Stroup DF, "Meta-analysis of observational studies in epidemiology : a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology(MOOSE)group", JAMA, 283, pp.2008~2012 (2000)
- Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses", Eur J Epidemiol, 25, pp.603~605 (2010)
- Iacopini F, "Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis(with videos)", Gastrointest Endosc, 82, pp.734~738 (2015)
- Kasuga K, "Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis", United European Gastroenterol J, 9, pp.964~972 (2021)
- Kochhar G, "Endoscopic submucosal dissection for flat colonic polyps in patients with inflammatory bowel disease : a single-center experience", Inflamm Bowel Dis, 24, pp.e14~e15 (2018)
- Kinoshita S, "Endoscopic submucosal dissection in patients with ulcerative colitis", Digestion, 99, pp.27~32 (2019)
- Lightner AL, "Endoscopic submucosal dissection is safe and feasible, allowing for ongoing surveillance and organ preservation in patients with inflammatory bowel disease", Colorectal Dis, 23, pp.2100~2107 (2021)
- Matsumoto K, "Long-term outcomes after endoscopic submucosal dissection for ulcerative colitis-associated dysplasia", Digestion, 102, pp.205~215 (2021)
- Manta R, "Endoscopic submucosal dissection for visible dysplasia treatment in ulcerative colitis patients : cases series and systematic review of literature", J Crohns Colitis, 15, pp.165~168 (2021)
- Matsui A, "Real-world experience of endoscopic submucosal dissection for ulcerative colitis-associated neoplasia", Inflamm Intest Dis, 6, pp.70~77 (2021)
- Ngamruengphong S, "Endoscopic submucosal dissection for colorectal dysplasia in inflammatory bowel disease : a US multicenter study", Endosc Int Open, 10, pp.E354~E360 (2022)
- Nishio M, "An endoscopic treatment strategy for superficial tumors in patients with ulcerative colitis", J Gastroenterol Hepatol, 36, pp.498~506 (2021)
- Suzuki N, "Endoscopic submucosal dissection of colitis-related dysplasia", Endoscopy, 49, pp.1237~1242 (2017)
- Yang DH, "Outcomes of ulcerative colitis-associated dysplasia patients referred for potential endoscopic submucosal dissection", J Gastroenterol Hepatol, 34, pp.1581~1589 (2019)
- Puhan MA, "A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis", BMJ, 349, pp.g5630~ (2014)
- Alkandari A, "Endoscopic resections in inflammatory bowel disease : a multicentre European outcomes study", J Crohns Colitis, 13, pp.1394~1400 (2019)
- Yadav S, "Outcome of endoscopic resection of colonic polyps larger than 10 mm in patients with inflammatory bowel disease", Endosc Int Open, 7, pp.E994~E1001 (2019)
- Yu JX, "Trends in EMR for nonmalignant colorectal polyps in the United States", Gastrointest Endosc, 91, pp.124~131 (2020)
- Akintoye E, "Colorectal endoscopic submucosal dissection : a systematic review and meta-analysis", Endosc Int Open, 4, pp.E1030~E1044 (2016)
- Patel N, "Colorectal endoscopic submucosal dissection : systematic review of mid-term clinical outcomes", Dig Endosc, 28, pp.405~416 (2016)
- Mohapatra S, "Advanced endoscopic resection for colorectal dysplasia in inflammatory bowel disease : a meta-analysis", Endosc Int Open, 10, pp.E593~E601 (2022)
- Chen W, "Endoscopic resection for non-polypoid dysplasia in inflammatory bowel disease : a systematic review and meta-analysis", Surg Endosc, 35, pp.1534~1543 (2021)